Interestingly, CT_H was less effective than CF_L in reducing IL-6 and increasing IL-10 concentrations, suggesting an antagonism between the anti-inflammatory effects of the two drugs in the treatment of cholestasis. The gene discussed is IL10; the disease is cholestasis.